KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $462 | -30.9% | 10,105 | 0.0% | 0.20% | -21.1% |
| Q1 2024 | $669 | +66.4% | 10,105 | 0.0% | 0.25% | +69.6% |
| Q4 2023 | $402 | +24.8% | 10,105 | 0.0% | 0.15% | +33.3% |
| Q3 2023 | $322 | -20.7% | 10,105 | 0.0% | 0.11% | -11.2% |
| Q2 2023 | $406 | -5.8% | 10,105 | 0.0% | 0.12% | -6.7% |
| Q1 2023 | $431 | -11.1% | 10,105 | 0.0% | 0.13% | -17.3% |
| Q4 2022 | $485 | -99.9% | 10,105 | 0.0% | 0.16% | +23.7% |
| Q3 2022 | $380,000 | +36.2% | 10,105 | 0.0% | 0.13% | +39.4% |
| Q2 2022 | $279,000 | -49.3% | 10,105 | 0.0% | 0.09% | -43.7% |
| Q1 2022 | $550,000 | -6.9% | 10,105 | 0.0% | 0.17% | +3.1% |
| Q4 2021 | $591,000 | +47.8% | 10,105 | 0.0% | 0.16% | +52.8% |
| Q3 2021 | $400,000 | -6.8% | 10,105 | 0.0% | 0.11% | -3.6% |
| Q2 2021 | $429,000 | – | 10,105 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |